Introducing Our New Next Generation Sequencing (NGS) Lab: Faster, More Precise Cancer Care—Delivered Directly to Patients

At Maryland Oncology Hematology (MOH), our mission has always been to bring world‑class cancer care closer to home. Today, we’re proud to announce one of our most significant advancements yet: the launch of our state‑of‑the‑art Next Generation Sequencing (NGS) laboratory—an in‑house facility designed to deliver faster, more personalized, and more precise cancer insights for our patients.

What Is Next Generation Sequencing (NGS)?

Next Generation Sequencing is a cutting‑edge technology that analyzes the genetic makeup of a patient’s tumor. Instead of looking at one gene at a time, NGS can examine hundreds of genes simultaneously, identifying mutations or changes that help oncologists understand:

• Why a cancer developed
• How it is likely to behave
• Which treatments are most likely to work
• Whether a patient is eligible for targeted therapies or clinical trials

NGS is one of the most powerful tools shaping the future of precision oncology—and now, it’s available right here at MOH.

Why Having Our Own NGS Lab Matters

While many oncology practices must send samples to outside laboratories—sometimes across the country—MOH is among a small number of independent oncology practices in the United States to own and operate its own fully equipped NGS laboratory. “Having direct control over genomic testing means we can accelerate diagnoses and begin tailored treatment plans sooner,” says Maryland Oncology Hematology’s Dr. Kashif Firozvi. “For patients, that time matters.”

This is more than a convenience. It’s a game-changer.

Faster Results

When testing is sent out, patients may wait three to four weeks or more for results. With in‑house sequencing, we can dramatically reduce turnaround times. Faster insights mean oncologists can make treatment decisions sooner—when every day matters.

Greater Precision

Our laboratory is designed specifically for cancer-focused sequencing. Because our molecular team works directly with our oncologists, we ensure that the right tests are ordered for the right patients, and that results are interpreted within the full context of their cancer journey.

Direct Access, No Barriers

By owning the lab, MOH can offer high‑level, comprehensive genomic testing directly to our patients, without the uncertainties that come with outside vendors—delays, extra costs, or limited test menus.

A Personalized Experience

With on‑site experts and testing integrated into our care model, patients receive a more seamless, connected experience. Your care team can review your genomic results in real time, answer questions quickly, and design a treatment plan that reflects the most advanced science available.

Transforming Cancer Care Through Precision Medicine

Cancer care is no longer one‑size‑fits‑all. Treatments today can be tailored to the unique genetic fingerprint of a patient’s cancer. Our new NGS lab allows MOH to deliver this level of specialization to more patients than ever before.

This lab represents:

• A major investment in innovation
• A commitment to providing the highest standards in oncology
• A promise that every patient has access to the powerful tools shaping the future of cancer treatment

Most importantly, it reflects our belief that the best cancer care should be accessible close to home—without compromising quality, speed, or precision.

Bringing the Future of Cancer Care to Maryland

As one of the few independent oncology practices nationally to operate an in‑house NGS lab, Maryland Oncology Hematology continues to lead the way in patient-centered cancer care. This advancement allows us to honor our long‑standing commitment: providing advanced treatments and technologies, delivered by experts who know you and support you every step of the way.

If you or a loved one is facing a cancer diagnosis, our team is here—with the expertise, compassion, and cutting‑edge tools needed to guide the journey forward.